Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth

Spontaneous preterm birth is one of the most pressing issues in obstetrics, as it remains one of the leading causes of newborn morbidity and mortality. Pending issues of aetiology, pathogenesis, and absence of medicinal products indicated for the treatment of spontaneous preterm labour pose a challe...

Full description

Saved in:
Bibliographic Details
Main Authors: E. A. Sоkоvа, R. A. Chilova, O. A. Demidova, K. O. Akopov
Format: Article
Language:Russian
Published: Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’) 2019-09-01
Series:Регуляторные исследования и экспертиза лекарственных средств
Subjects:
Online Access:https://www.vedomostincesmp.ru/jour/article/view/235
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849249597747101696
author E. A. Sоkоvа
R. A. Chilova
O. A. Demidova
K. O. Akopov
author_facet E. A. Sоkоvа
R. A. Chilova
O. A. Demidova
K. O. Akopov
author_sort E. A. Sоkоvа
collection DOAJ
description Spontaneous preterm birth is one of the most pressing issues in obstetrics, as it remains one of the leading causes of newborn morbidity and mortality. Pending issues of aetiology, pathogenesis, and absence of medicinal products indicated for the treatment of spontaneous preterm labour pose a challenge for rational pharmacotherapy. The paper presents the results of a scientific literature review on the problem of rational pharmacotherapy of spontaneous preterm labour using tocolytic drugs — calcium channel blockers, cyclooxygenase inhibitors. The paper summarises specific pharmacokinetic parameters of these drugs during pregnancy. It discusses pharmacogenetic aspects of using tocolytic drugs in pregnant women and their potential clinical effects. It was demonstrated that women with threatened miscarriage had high interindividual variability in nifedipine plasma concentrations depending on CYP3A5 genotype. It was shown that certain genetic polymorphisms of CYP2C9 may lead to an increased metabolic rate and an increase in indomethacin clearance resulting in the reduction of its efficacy. Yet, there is minimal research regarding this issue. Therefore, further research is needed to assess the impact of CYP3A5 and CYP2C9 genotypes on the efficacy and safety of nifedipine and indomethacin used as tocolytic drugs in obstetrics.
format Article
id doaj-art-17d473bf9d594824adf18dfbeba71d85
institution Kabale University
issn 3034-3062
3034-3453
language Russian
publishDate 2019-09-01
publisher Federal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)
record_format Article
series Регуляторные исследования и экспертиза лекарственных средств
spelling doaj-art-17d473bf9d594824adf18dfbeba71d852025-08-20T03:57:31ZrusFederal State Budgetary Institution ‘Scientific Centre for Expert Evaluation of Medicinal Products’ of the Ministry of Health of the Russian Federation (FSBI ‘SCEEMP’)Регуляторные исследования и экспертиза лекарственных средств3034-30623034-34532019-09-019316216610.30895/1991-2919-2019-9-3-162-166203Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm BirthE. A. Sоkоvа0R. A. Chilova1O. A. Demidova2K. O. Akopov3Scientific Centre for Expert Evaluation of Medicinal ProductsI. M. Sechenov First Moscow State Medical UniversityScientific Centre for Expert Evaluation of Medicinal ProductsI. M. Sechenov First Moscow State Medical UniversitySpontaneous preterm birth is one of the most pressing issues in obstetrics, as it remains one of the leading causes of newborn morbidity and mortality. Pending issues of aetiology, pathogenesis, and absence of medicinal products indicated for the treatment of spontaneous preterm labour pose a challenge for rational pharmacotherapy. The paper presents the results of a scientific literature review on the problem of rational pharmacotherapy of spontaneous preterm labour using tocolytic drugs — calcium channel blockers, cyclooxygenase inhibitors. The paper summarises specific pharmacokinetic parameters of these drugs during pregnancy. It discusses pharmacogenetic aspects of using tocolytic drugs in pregnant women and their potential clinical effects. It was demonstrated that women with threatened miscarriage had high interindividual variability in nifedipine plasma concentrations depending on CYP3A5 genotype. It was shown that certain genetic polymorphisms of CYP2C9 may lead to an increased metabolic rate and an increase in indomethacin clearance resulting in the reduction of its efficacy. Yet, there is minimal research regarding this issue. Therefore, further research is needed to assess the impact of CYP3A5 and CYP2C9 genotypes on the efficacy and safety of nifedipine and indomethacin used as tocolytic drugs in obstetrics.https://www.vedomostincesmp.ru/jour/article/view/235pregnancytocolytic drugpharmacokineticspharmacogeneticssafetyefficacynifedipineindomethacincyp-450
spellingShingle E. A. Sоkоvа
R. A. Chilova
O. A. Demidova
K. O. Akopov
Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
Регуляторные исследования и экспертиза лекарственных средств
pregnancy
tocolytic drug
pharmacokinetics
pharmacogenetics
safety
efficacy
nifedipine
indomethacin
cyp-450
title Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
title_full Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
title_fullStr Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
title_full_unstemmed Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
title_short Clinical Pharmacology Aspects of Some Tocolytic Drugs Used in Pregnant Women at Risk of Preterm Birth
title_sort clinical pharmacology aspects of some tocolytic drugs used in pregnant women at risk of preterm birth
topic pregnancy
tocolytic drug
pharmacokinetics
pharmacogenetics
safety
efficacy
nifedipine
indomethacin
cyp-450
url https://www.vedomostincesmp.ru/jour/article/view/235
work_keys_str_mv AT easokova clinicalpharmacologyaspectsofsometocolyticdrugsusedinpregnantwomenatriskofpretermbirth
AT rachilova clinicalpharmacologyaspectsofsometocolyticdrugsusedinpregnantwomenatriskofpretermbirth
AT oademidova clinicalpharmacologyaspectsofsometocolyticdrugsusedinpregnantwomenatriskofpretermbirth
AT koakopov clinicalpharmacologyaspectsofsometocolyticdrugsusedinpregnantwomenatriskofpretermbirth